MGMT and glioblastoma: There have been multiple combination treatments used with TMZ in several clinical trials for high-grade GBM patients, including radiotherapy and immunotherapy, but these co-treatments are limited due to various resistance factors, including the MGMT gene promoter and the ability of a drug to cross the blood–brain barrier [89,90].